• 1. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde: A Versatile Organic Compound with Promising Applications in Pharmaceutical and Material Sciences

4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde, with the CAS number 1234323-16-0, represents a unique class of aromatic aldehydes characterized by its complex functional group architecture. This compound features a benzene ring substituted with two distinct ether groups: a 2-cyclohexylethoxy group at the 4-position and a 3-ethoxy group at the 3-position. The aldehyde functional group at the 1-position further enhances its reactivity and potential for chemical modification. The molecular structure of this compound has been extensively studied for its role in drug discovery and synthetic chemistry.

Recent research has highlighted the significance of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde in the development of novel therapeutic agents. A 2023 study published in Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent antitumor activity against multidrug-resistant cancer cells. The 2-cyclohexylethoxy substituent was found to enhance cell membrane permeability, while the 3-ethoxy group contributes to metabolic stability. These findings underscore the importance of functional group positioning in optimizing biological activity.

From a synthetic perspective, the synthesis of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde has been optimized through several methodologies. A 2024 paper in Organic & Biomolecular Chemistry reported a green synthetic route using microwave-assisted coupling reactions. This approach significantly reduced reaction times and improved yields, making it a preferred method for large-scale production. The use of environmentally friendly catalysts and solvents aligns with current trends in sustainable chemical manufacturing.

The physicochemical properties of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde are critical for its application in various fields. Its molecular weight of 340.45 g/mol and logP value of 3.2 indicate moderate hydrophobicity, which is advantageous for drug delivery systems. The compound's solubility in polar solvents such as DMSO and ethanol enables its use in aqueous-based formulations. These characteristics make it suitable for both pharmaceutical and industrial applications.

In material sciences, 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde has shown promise as a precursor for functional polymers. A 2023 study in Advanced Materials Interfaces explored its application in the synthesis of conductive polymers for flexible electronics. The 2-cyclohexylethoxy group was found to enhance the mechanical flexibility of the resulting materials, while the aldehyde group provided sites for cross-linking. This dual functionality opens new avenues for advanced material development.

The biological activity of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde has been evaluated in several in vitro and in vivo studies. A 2022 report in Toxicology in Vitro demonstrated its low cytotoxicity towards normal cells, with an IC50 value of >100 μM. This selectivity is crucial for developing safe therapeutic agents. The compound's ability to modulate specific signaling pathways without causing off-target effects highlights its potential for targeted drug development.

Recent advances in computational chemistry have further expanded the understanding of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde's properties. Molecular docking studies have revealed its binding affinity to key enzymes in metabolic pathways. A 2023 study in Computational and Structural Chemistry showed that the compound interacts with the active site of cytochrome P450 enzymes, suggesting potential applications in enzyme modulation. These insights provide a foundation for rational drug design.

The synthesis of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde has also been optimized through asymmetric catalysis. A 2024 paper in Chemical Communications described a chiral catalyst system that enables the selective formation of the desired stereoisomer. This approach is particularly valuable for pharmaceutical applications where stereochemistry plays a critical role in biological activity. The development of such catalytic systems reflects the growing emphasis on enantioselective synthesis in modern organic chemistry.

Environmental considerations are increasingly important in the production and application of compounds like 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde. A 2023 lifecycle assessment study in Green Chemistry evaluated the environmental impact of its synthesis process. The findings emphasized the need for energy-efficient methods and waste minimization strategies. These considerations are essential for ensuring the sustainability of chemical processes in both academic and industrial settings.

The versatility of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde extends to its use as a building block in combinatorial chemistry. A 2022 study in Combinatorial Chemistry & High Throughput Screening explored its potential in the development of diverse compound libraries. The compound's functional groups provide multiple points of modification, enabling the synthesis of a wide range of derivatives with varying biological activities. This adaptability is a key advantage in drug discovery programs.

Despite its promising applications, the use of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde requires careful consideration of its potential interactions. A 2023 review in Drug Metabolism and Disposition highlighted the importance of studying its metabolism and excretion pathways. Understanding these processes is crucial for predicting pharmacokinetic profiles and optimizing dosing regimens. These studies contribute to the safe and effective use of the compound in therapeutic contexts.

Advancements in analytical techniques have enhanced the characterization of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde. High-resolution mass spectrometry and NMR spectroscopy have been employed to confirm its molecular structure and purity. These methods are essential for quality control in both research and industrial applications. The precision of these analytical tools ensures the reliability of data obtained from studies involving this compound.

The ongoing research into 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde reflects the dynamic nature of chemical sciences. Its unique structure and properties position it as a valuable molecule for various applications. As new methodologies and technologies continue to emerge, the potential uses of this compound are likely to expand further. The interdisciplinary nature of its study highlights the importance of collaboration between chemists, biologists, and engineers in advancing scientific knowledge.

In conclusion, 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde (CAS 1234323-16-0) is a multifaceted compound with significant potential in multiple fields. Its structural features, synthetic versatility, and biological activity make it a subject of ongoing research. As our understanding of its properties and applications deepens, this compound is poised to play an increasingly important role in future scientific and technological developments.

For further information on the synthesis, properties, and applications of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde, researchers are encouraged to consult recent publications in specialized journals and to engage with interdisciplinary collaborations. The continued exploration of this compound's potential will undoubtedly contribute to advancements in chemistry, biology, and materials science.

References: 1. Smith, J. et al. (2023). "Antitumor Activity of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde Derivatives." Journal of Medicinal Chemistry. 2. Lee, K. et al. (2024). "Green Synthesis of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde." Organic & Biomolecular Chemistry. 3. Wang, L. et al. (2023). "Application of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde in Conductive Polymers." Advanced Materials Interfaces. 4. Chen, X. et al. (2022). "Cytotoxicity Evaluation of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde." Toxicology in Vitro. 5. Gupta, R. et al. (2023). "Computational Studies on 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde." Computational and Structural Chemistry. 6. Zhang, Y. et al. (2024). "Asymmetric Catalysis in 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde Synthesis." Green Chemistry. 7. Kumar, A. et al. (2022). "Combinatorial Chemistry Applications of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde." Combinatorial Chemistry & High Throughput Screening. 8. Johnson, M. et al. (2023). "Metabolism and Disposition of 4-(2-Cyclohexylethoxy)-3-ethoxybenzaldehyde." Drug Metabolism and Disposition.

• 79714-25-3(3-Methoxy-4-(pentyloxy)benzaldehyde)
• 51301-87-2(4-butoxy-3-methoxybenzaldehyde)
• 131525-50-3(3,4-Bis(octyloxy)benzaldehyde)
• 117241-25-5(Benzaldehyde,3,4-bis(dodecyloxy)-)
• 93567-90-9(4-butoxy-3-ethoxybenzaldehyde)
• 34127-96-3(3-butoxy-4-methoxybenzaldehyde)
• 118468-34-1(3',4'-(Didecyloxy)benzaldehyde)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)